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Knowledge of the consumption behavior of cannabis
consumers is important in many forensic and clinical
circumstances, for example for deciding on medical treatment
or administrative and legal consequences, such as suspension of
the driver’s license. The concentration of the cannabis metabolite
11-nor-9-carboxy-∆
9
-tetrahydrocannabinol (THCCOOH) serves
as a diagnostic marker to distinguish between occasional and
frequent smokers. In Switzerland, a THCCOOH blood level of
40 µg/L is currently used by forensic experts as decision limit
for regular consumption. However, this threshold concentration
was found to be correlated with a low sensitivity. Therefore, an
additional and/or enhanced indicator of cannabis consumption
frequency would be beneficial. Since THCCOOH in blood is
extensively glucuronidated, we assume that the blood level of
THCCOOH-glucuronide could serve as an additional parameter
for assessing the frequency of cannabis use. To verify this
assumption, we have developed a column-switching LC-MS/
MS method for the simultaneous quantification of free and
glucuronidated THCCOOH in whole blood.
The use of a trapping column for on-line sample enrichment
and purification and an analytical column for separation and
detection allows us to prepare blood samples by a simple
protein precipitation step without sample preconcentration by
evaporation and reconstitution. Employing two columns, each
containing a different stationary phase, provides the needed
selectivity to obtain excellent separation of the two analytes
within a total run time of only 4.5 min. Detection of the analytes
is accomplished by electrospray ionization in positive ion mode
and selected reaction monitoring using a triple-stage quadrupole
mass spectrometer.
This method was used to analyze blood samples from a
controlled cannabis administration study and therefore provided
the required pharmacokinetic data for investigating the suitability
of free and glucuronidated THCCOOH as indicators of cannabis
consumption frequency.
Column-switching chromatography combined with
tandem mass spectrometry allows for simultaneous and
ultra-rapid quantification of THCCOOH and THCCOOH-
glucuronide in whole blood, requiring only minimal sample
pre-treatment, and offers new possibilities for assessing
cannabis consumption behavior.
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11-nor-9-carboxy-∆
9
-tetrahydrocannabinol (THCCOOH) and its
glucuronide conjugate are metabolites of ∆
9
-tetrahydrocannabinol
(THC), the major psychoactive component of cannabis. Their
quantification in whole blood is of interest for interpreting cannabis
consumption behavior.
Chromatogram of an authentic whole blood specimen from a cannabis
consumer (THCCOOH, 97.6 µg/L; THCCOOH-glucuronide, 296 µg/L).
The purple peak at 2.16 min corresponds to the THCCOOH fragment
originating from in-source decay of the glucuronide.
